Subscapularis Repair in Shoulder Replacement for Shoulder Arthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate the effectiveness of shoulder replacement surgery with and without repairing the subscapularis muscle. Researchers will compare patient outcomes in terms of feeling and function over two years. Participants will be divided into two groups: one will undergo RTSA with subscapularis repair, and the other will undergo RTSA without it. The trial seeks individuals with shoulder arthritis or related issues who are planning their first shoulder replacement surgery. Those whose shoulder conditions match these criteria and can attend follow-up visits may find this trial suitable. As an Early Phase 1 trial, this research focuses on understanding the surgical approach in people, offering participants a chance to contribute to pioneering medical insights.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that repairing the subscapularis muscle during reverse total shoulder replacement surgery is safe. Several studies confirm its safety, though it may not offer additional clinical or functional benefits. Specifically, patients who underwent this repair demonstrated improved shoulder movement, particularly in internal rotation, after 12 months.
In early trials, safety remains a key concern. Testing this treatment in humans has indicated it is safe enough to proceed. However, early trials provide limited information on long-term effects or rare issues. It is important to consider both the potential benefits and risks before deciding to join a clinical trial.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the technique of subscapularis repair in shoulder replacement for shoulder arthritis because it could potentially enhance the stability and function of the shoulder joint post-surgery. Most current treatments for shoulder arthritis, like standard reverse total shoulder arthroplasty (RTSA), often do not include subscapularis repair, which may limit shoulder strength and mobility. By incorporating subscapularis repair, this method aims to improve outcomes by restoring a more natural muscle function, possibly leading to better shoulder movement and patient satisfaction.
What evidence suggests that this trial's treatments could be effective for shoulder arthritis?
This trial will compare two approaches to reverse total shoulder arthroplasty (RTSA) for shoulder arthritis: RTSA with subscapularis repair and RTSA without it. Research has shown that RTSA generally improves shoulder movement, provides better results, and reduces pain for individuals with shoulder arthritis. However, studies have found that adding subscapularis repair to RTSA does not offer additional benefits. For instance, shoulder strength, including movements like lifting the arm or rotating it inwards or outwards, remains the same whether the subscapularis is repaired or not. Additionally, complication rates are similar for both methods, with only a small difference in dislocation rates. Overall, while RTSA alone is effective, repairing the subscapularis muscle does not enhance its effectiveness.12678
Who Is on the Research Team?
Jarret Woodmass
Principal Investigator
Pan Am Clinic
Are You a Good Fit for This Trial?
This trial is for individuals with shoulder arthritis or similar conditions who need their first RTSA implant and have a low-grade fatty infiltration in the subscapularis muscle. It's not for those who've had previous shoulder replacements, suffer from inflammatory arthritis, can't communicate in English, or won't be able to attend follow-up visits for 2 years.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery
Participants undergo RTSA with or without subscapularis repair
Postoperative Follow-up
Participants are monitored for clinical and functional outcomes, including PROMs, shoulder function, and surgical complications
Long-term Follow-up
Participants continue to be monitored for long-term outcomes and any late complications
What Are the Treatments Tested in This Trial?
Interventions
- RTSA without subscapularis repair
- RTSA with subscapularis repair
RTSA without subscapularis repair is already approved in European Union, United States for the following indications:
- Rotator cuff arthropathy
- Shoulder pseudoparalysis
- Massive rotator cuff tear
- Fracture
- Tumor
- Instability
- Revision arthroplasty
- Rotator cuff arthropathy
- Shoulder pseudoparalysis
- Massive rotator cuff tear
- Fracture
- Tumor
- Instability
- Revision arthroplasty
Find a Clinic Near You
Who Is Running the Clinical Trial?
Panam Clinic
Lead Sponsor
University of Manitoba
Collaborator